INNATE PHARMA EUR0.05INNATE PHARMA EUR0.05INNATE PHARMA EUR0.05

INNATE PHARMA EUR0.05

No trades
See on Supercharts

Price target

7.180.00 0.00%
The 7 analysts offering 1 year price forecasts for 0EVI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings to 0EVI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

0EVI EPS for the last quarter is −0.12 EUR despite the estimation of −0.40 EUR. In the next quarter EPS is expected to reach −0.36 EUR. Track more of INNATE PHARMA EUR0.05 financials and stay on top of what is up with the company.
In the next quarter INNATE PHARMA EUR0.05 revenue is expected to reach ‪8.27 M‬ EUR. Check out INNATE PHARMA EUR0.05 revenue and earnings and make informed decisions.
According to analysts, 0EVI price target is 7.18 EUR with a max estimate of 10.69 EUR and a min estimate of 2.25 EUR. Check if this forecast comes true in a year, meanwhile keep track of the current situation with 0EVI news and stock market news.
We've gathered opinions of 7 analysts rating 0EVI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.